P458: HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA

P458: HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA

Bibliografske podrobnosti
Main Authors:	Benjamin Dannenmann, Maksim Klimiankou, Cornelia Zeidler, Karl Welte, Julia Skokowa
Format:	Article
Jezik:	English
Izdano:	Wiley 2023-08-01
Serija:	HemaSphere
Online dostop:	http://journals.lww.com/10.1097/01.HS9.0000968740.39781.cd

Podobne knjige/članki

Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring <i>ELANE</i> mutations
od: Alexander Zeidler, et al.
Izdano: (2023-10-01)

A zebrafish model for HAX1-associated congenital neutropenia
od: Larissa Doll, et al.
Izdano: (2020-04-01)

P1357: MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA
od: Masoud Nasri, et al.
Izdano: (2023-08-01)

P779: LONG-TERM COURSE OF HAX1-RELATED CONGENITAL NEUTROPENIA: AN ANALYSIS OF THE EUROPEAN SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY (SCNIR)
od: Denys Pogozhykh, et al.
Izdano: (2023-08-01)

P751: UNRAVELING THE DIFFERENT PATHOMECHANISMS OF CONGENITAL AND CYCLIC NEUTROPENIAS: CYCLIC EXPRESSION OF HEMATOPOIETIC STEM-CELL-SPECIFIC TRANSCRIPTION FACTORS IN CYCLIC NEUTROPENIA
od: Karl Alexander Zeidler, et al.
Izdano: (2023-08-01)

CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients
od: Masoud Nasri, et al.
Izdano: (2020-03-01)

Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene
od: Patcharee Komvilaisak, et al.
Izdano: (2023-11-01)

HAX1 mutation in an infant with severe congenital neutropenia
od: Aziz Eghbali, et al.
Izdano: (2010-02-01)

P750: A ZEBRAFISH MODEL FOR JAGN1-ASSOCIATED SEVERE CONGENITAL NEUTROPENIA
od: Larissa Doll, et al.
Izdano: (2023-08-01)

S178: A NEW HEREDITARY SYNDROME WITH SEVERE NEUTROPENIA AND NEUROLOGICAL INVOLVEMENT CAUSED BY THE AUTOSOMAL RECESSIVE COPZ1 MUTATION
od: Natalia Borbaran Bravo, et al.
Izdano: (2023-08-01)

Severe congenital neutropenia: pathophysiology of leukemogenic transformation
od: J. Skokowa, et al.
Izdano: (2022-11-01)

Digenic mutations in severe congenital neutropenia
od: Manuela Germeshausen, et al.
Izdano: (2010-07-01)

JMML WITH NRAS MUTATION IN ELANE ASSOCIATED SEVERE CONGENITAL NEUTROPENIA
od: Hilde Hylland Uhlving, et al.
Izdano: (2023-12-01)

Novel HAX1 Gene Mutation in a Vietnamese Boy with Severe Congenital Neutropenia
od: Tham Thi Tran, et al.
Izdano: (2018-01-01)

Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency
od: K. Matsubara, et al.
Izdano: (2007-12-01)

Novel HAX1 gene mutations associated to neurodevelopment abnormalities in two Italian patients with severe congenital neutropenia
od: Marina Lanciotti, et al.
Izdano: (2010-01-01)

RECURRENCE OF UNDERLYING CONGENITAL NEUTROPENIA WITHOUT MDS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN A PATIENT WITH ELANE-MUTATED CONGENITAL NEUTROPENIA AND SECONDARY MDS
od: Ingrid Furlan, et al.
Izdano: (2023-12-01)

Expanding the genetic landscape of congenital neutropenia: <i>CXCR2</i> mutations in three families revealed through whole exome sequencing
od: Maksim Klimiankou, et al.
Izdano: (2024-08-01)

A novel compound heterozygous HAX1 mutation in a Chinese patient with severe congenital neutropenia and chronic myelomonocytic leukemia transformation but without neurodevelopmental abnormalities
od: Sheng-Li Xue, et al.
Izdano: (2012-02-01)

Congenital and Acquired Chronic Neutropenias: Challenges, Perspectives and Implementation of the EuNet-INNOCHRON Action
od: Helen A. Papadaki, et al.
Izdano: (2020-06-01)

Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis
od: Tatsuya Morishima, et al.
Izdano: (2014-01-01)

Clinical Characteristics and Treatment Response of a Novel ELANE Gene Mutation (c.295_303del) in Congenital Neutropenia
od: Junjie Ning
Izdano: (2024-02-01)

Case report: A cyclic neutropenia patient with ELANE mutation accompanied by hemophagocytic lymphohistiocytosis
od: Lang Yu, et al.
Izdano: (2024-11-01)

Professional haXe and Neko /
od: 295120 Ponticelli, Franco, et al.
Izdano: (2008)

Severe congenital neutropaenia with ELANE mutation: a case report
od: Tharindi Suriapperuma, et al.
Izdano: (2020-12-01)

Acute myeloid leukemia in SRP54‐mutated congenital neutropenia
od: Anthony Sabulski, et al.
Izdano: (2022-05-01)

Case Report: Characterization of known (c.607G>C) and novel (c.416C>G) ELANE mutations in two Mexican families with congenital neutropenia
od: María Enriqueta Núñez-Núñez, et al.
Izdano: (2023-09-01)

The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells
od: Lan Dan, et al.
Izdano: (2012-04-01)

Élan vital
od: Sergio Rafael Figallo Calzadilla
Izdano: (2024-01-01)

Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events
od: Onyemaechi N. Okolo, et al.
Izdano: (2017-01-01)

Squib: Preaching with Élan
od: Charles L. Campbell
Izdano: (2016-02-01)

Molecular basis of congenital neutropenia
od: Christoph Klein
Izdano: (2009-10-01)

Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
od: Yun Xu, et al.
Izdano: (2023-10-01)

NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells
od: Yun Xu, et al.
Izdano: (2021-02-01)

P780: G-CSF THERAPY IN EUROPEAN PATIENTS WITH SHWACHMAN-DIAMOND SYNDROME
od: Sabine Mellor-Heineke, et al.
Izdano: (2023-08-01)

Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry
od: Cornelia Zeidler, et al.
Izdano: (2014-08-01)

Gene correction of HAX1 reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells
od: Erik Pittermann, et al.
Izdano: (2017-06-01)

The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action
od: Francesca Fioredda, et al.
Izdano: (2023-04-01)

Lotus Elan : the complete story /
od: 441170 Taylor, Mike
Izdano: (1990)

Elan vital chez Bergson
od: محمود نوالی
Izdano: (2012-12-01)